Matthew L. Sherman, EVP & Chief Medical Officer at ACCELERON PHARMA INC (XLRN), sold 4,600 shares at $38.28 ($177K) on 2018-04-03, disclosed to the SEC on 2018-04-04.
Seasonal sale ($177k) by EVP & Chief Medical Officer — this insider has traded XLRN in April in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.28 | 3,700 | $142K | 80.1% |
| 2 | $39.04 | 900 | $35K | 19.9% |
| Total | $38.43 avg | 4,600 | $177K | 100% |
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-10-04 | $37K | — | Filing → |